These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 33765230)

  • 1. Bone Mineral Disease After Kidney Transplantation.
    Torregrosa JV; Ferreira AC; Cucchiari D; Ferreira A
    Calcif Tissue Int; 2021 Apr; 108(4):551-560. PubMed ID: 33765230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survey of attitudes of physicians toward the current evaluation and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).
    Souqiyyeh MZ; Shaheen FA
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):93-101. PubMed ID: 20061700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kidney bone disease and mortality in CKD: revisiting the role of vitamin D, calcimimetics, alkaline phosphatase, and minerals.
    Kalantar-Zadeh K; Shah A; Duong U; Hechter RC; Dukkipati R; Kovesdy CP
    Kidney Int Suppl; 2010 Aug; (117):S10-21. PubMed ID: 20671739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic Kidney Disease-Mineral Bone Disease Biomarkers in Kidney Transplant Patients.
    Hasparyk UG; Vigil FMB; Bartolomei VS; Nunes VM; Simões E Silva AC
    Curr Med Chem; 2022 Aug; 29(31):5230-5253. PubMed ID: 35306980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical Clusters as Substitutes of Bone Biopsies in Kidney Transplant Patients.
    Ferreira AC; Mendes M; Silva C; Cotovio P; Aires I; Navarro D; Caeiro F; Salvador R; Correia B; Cabral G; Nolasco F; Ferreira A
    Calcif Tissue Int; 2024 Mar; 114(3):267-275. PubMed ID: 38253933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CKD-MBD post kidney transplantation.
    Haffner D; Leifheit-Nestler M
    Pediatr Nephrol; 2021 Jan; 36(1):41-50. PubMed ID: 31858226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of mineral and bone disorder after kidney transplantation.
    Kalantar-Zadeh K; Molnar MZ; Kovesdy CP; Mucsi I; Bunnapradist S
    Curr Opin Nephrol Hypertens; 2012 Jul; 21(4):389-403. PubMed ID: 22614626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with calcimimetics in kidney transplantation.
    Morales E; Gutierrez E; Andres A
    Transplant Rev (Orlando); 2010 Apr; 24(2):79-88. PubMed ID: 20303456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone health and vascular calcification relationships in chronic kidney disease.
    Spasovski GB
    Int Urol Nephrol; 2007; 39(4):1209-16. PubMed ID: 17899431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges in the therapy of secondary hyperparathyroidism.
    Wood C; González EA; Martin KJ
    Ther Apher Dial; 2005 Feb; 9(1):4-8. PubMed ID: 15828898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of mineral and bone disorders in renal transplant recipients.
    Damasiewicz MJ; Ebeling PR
    Nephrology (Carlton); 2017 Mar; 22 Suppl 2():65-69. PubMed ID: 28429555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Renal osteodystrophy (3); its treatment in dialysis patients].
    Ghitu S; Oprisiu R; Benamar L; Said S; Tataru Albu A; Arsenescu I; el Esper N; Morinière P; Fournier A
    Nephrologie; 2000; 21(8):413-24. PubMed ID: 11213385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone Disease in Chronic Kidney Disease and Kidney Transplant.
    Bellorin-Font E; Rojas E; Martin KJ
    Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Role of FGF23-Klotho axis in CKD-MBD].
    Komaba H
    Clin Calcium; 2010 Jul; 20(7):1028-36. PubMed ID: 20585181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CKD-mineral and bone disorder management in kidney transplant recipients.
    Alshayeb HM; Josephson MA; Sprague SM
    Am J Kidney Dis; 2013 Feb; 61(2):310-25. PubMed ID: 23102732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parathyroid function in chronic kidney disease: role of FGF23-Klotho axis.
    Koizumi M; Komaba H; Fukagawa M
    Contrib Nephrol; 2013; 180():110-23. PubMed ID: 23652554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D, parathyroid hormone, and bone mineral density status in kidney transplant recipients.
    Savaj S; Ghods FJ
    Iran J Kidney Dis; 2012 Jul; 6(4):295-9. PubMed ID: 22797100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profile of chronic kidney disease related-mineral bone disorders in newly diagnosed advanced predialysis diabetic kidney disease patients: A hospital based cross-sectional study.
    Ray S; Beatrice AM; Ghosh A; Pramanik S; Bhattacharjee R; Ghosh S; Raychaudhury A; Mukhopadhyay S; Chowdhury S
    Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S931-S937. PubMed ID: 28728874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.